Delivery Order SPE2DB22D1106-SPE2DB25FEZE7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 tablets of Meclizine 25 mg, a medication commonly used to treat nausea and vertigo. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $2,506.47 and an ultimate completion date of July 25, 2025. The place of performance is AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- This federal contract award, valued at $1,647.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,528,681 units of the medication Meclizine 25 mg tablets, with a completion date of May 8, 2024. This delivery order contract is a firm fixed-price arrangement. The contract is not associated with any set-aside designation, indicating open competition....
- This federal contract award is a delivery order valued at $1,072.32 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of MECLIZINE 25 MG TABLET 100S, a medication, with a performance period ending on July 10, 2025. This order is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $55,480 to Amerisourcebergen Drug Corporation for the supply of 4561937695 tablets of 25mg meclizine. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 25, 2023 under the terms of the contract. The parent company, Amerisourcebergen Corporation, will support performance through its Amerisourcebergen Corporation...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Mefloquine HCl 250 mg tablets in unit dose packaging (25-count) with a contract value of $1,375.49. This competitively awarded, non-set-aside delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries a firm fixed price structure. The awarded vendor, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mefloquine HCL 250 mg tablets in unit dose packaging of 25 tablets. This is a firm fixed-price delivery order with a ceiling value of $1,813.75 and a completion date of July 28, 2025. The award was made competitively with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,105.96 for metoclopramide 10mg tablets (25-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a $1,911.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for mefloquine hydrochloride, a pharmaceutical product, and has a completion date of February 13, 2024. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025 to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZE7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,019.89 to AmerisourceBergen Drug Corp for Meclizine 25 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Through this flexible contract vehicle, AmerisourceBergen delivers medical commodities to customers including the Defense Health Agency and U.S. Coast Guard, with the Meclizine 25 mg tablets representing a routine pharmaceutical supply fulfillment under the established contractual framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/23/25 |